CAROL ALTER , M.D., ANDREW CARLO , M.D., HENRY HARBIN, MICHAEL SCHOENBAUM , Ph.D. Psychiatric News Published Online:3 Jul 2019 “This … column, written by some of the nation’s experts in mental health policy and payment, summarizes recent information on billing codes and other factors...Read More »
As the recognition of mental illness becomes more prevalent, the need for treatment resources at all levels of care becomes increasingly more vital. These resources include, but are not limited to, longterm care facilities, short-term care facilities, acute care units, emergency rooms,...Read More »
In the context of highly publicized episodes of mass violence in this country, the question often arises as to the role of mental illness as a factor impelling the perpetrators of violence. Therefore, it is important to clarify this matter...Read More »
Positions taken on the following bills by the NJPA Board of Trustees are conveyed to the Association lobby firm. The firm will track and monitor these bills on behalf of the Association and actively advise lawmakers of the NJPA position...Read More »
Marijuana legalization has been promoted as a public health measure to decrease drug-related crime, as a solution to the harms caused by marijuana criminalization, including incarceration, and as a significant source of tax revenue. These claims have not been validated...Read More »
In New Jersey, along with our nation as a whole, we are facing a true epidemic of opioid overuse and addiction, which may lead to death by overdose, either deliberate or accidental. Overdose deaths involving prescription or illicit opioids have...Read More »
Healthcare insurance companies, through Pharmacy Benefit Management (PBM) policies, typically employ drug formularies which designate which drugs they will pay for, under what circumstances and in what quantities, with or without co-pays. Physicians, particularly those experienced in the medical specialty...Read More »
The New Jersey Psychiatric Association supports the use of telemedicine in psychiatry, which can safely provide access to care when properly used and certain standards are observed. The use of telemedicine in psychiatry shall meet all applicable federal and state...Read More »
Tobacco Use Disorder (TUD) is the major cause of morbidity and mortality among people with mental illnesses, including substance disorders (SUD). Reasons for this include the inherent toxicity of chemicals in smoke, coupled with the fact that two to four...Read More »
In September 2022, the NJPA adopted the APA's position statement.
NJPA Board Approved on September 14, 2022 · Position Statement
NJPA Becomes an Approved Subcontractor of the N.J. Pediatric Psychiatry Collaborative Care Initiative Program designed...
While the New Jersey Psychiatric Association (NJPA) makes every effort to post accurate and reliable information, it does not guarantee that the information on this website is complete, accurate or up to date, nor does it assume responsibility for the use or application of any posted material. The NJPA takes no responsibility for any error, omission or other discrepancy between the electronic and any printed versions of documents. This website is intended solely for the purpose of electronically providing members, non-member psychiatrists and the public with information and convenient access to a variety of resources. The NJPA cannot provide specific advice or counsel, whether medical, legal or otherwise. This website links to websites maintained by other entities. Although efforts have been taken to assure that these linked websites are maintained by reputable organizations, the NJPA is not responsible for the information and opinions expressed in those linked sites.